Correlation Between Alvotech and Intra Cellular
Can any of the company-specific risk be diversified away by investing in both Alvotech and Intra Cellular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alvotech and Intra Cellular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alvotech and Intra Cellular Therapies, you can compare the effects of market volatilities on Alvotech and Intra Cellular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alvotech with a short position of Intra Cellular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alvotech and Intra Cellular.
Diversification Opportunities for Alvotech and Intra Cellular
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Alvotech and Intra is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Alvotech and Intra Cellular Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intra Cellular Therapies and Alvotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alvotech are associated (or correlated) with Intra Cellular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intra Cellular Therapies has no effect on the direction of Alvotech i.e., Alvotech and Intra Cellular go up and down completely randomly.
Pair Corralation between Alvotech and Intra Cellular
If you would invest 845.00 in Alvotech on July 23, 2025 and sell it today you would earn a total of 14.00 from holding Alvotech or generate 1.66% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 2.44% |
Values | Daily Returns |
Alvotech vs. Intra Cellular Therapies
Performance |
Timeline |
Alvotech |
Intra Cellular Therapies |
Risk-Adjusted Performance
Weakest
Weak | Strong |
Alvotech and Intra Cellular Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Alvotech and Intra Cellular
The main advantage of trading using opposite Alvotech and Intra Cellular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alvotech position performs unexpectedly, Intra Cellular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intra Cellular will offset losses from the drop in Intra Cellular's long position.Alvotech vs. Supernus Pharmaceuticals | Alvotech vs. HUTCHMED DRC | Alvotech vs. Indivior PLC Ordinary | Alvotech vs. Bausch Health Companies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |